Typicality: | 0.518 |
Saliency: | 0.628 |
for eight weeks | 10 | temporal |
daily | 7 | temporal |
for 12 weeks | 7 | temporal |
group → take → placebo | 165 |
group → take → the placebo | 50 |
group → use → placebo | 12 |
group → consume → placebo | 12 |
negative | neutral | positive |
0.167 | 0.670 | 0.163 |
Raw frequency | 239 |
Normalized frequency | 0.628 |
Modifier score | 0.500 |
Perplexity | 224.717 |